Invesaro

Stocks MRNA Earnings

Earnings

Moderna, Inc. (MRNA) earnings

Quarterly results of Moderna, Inc. as filed with the SEC: revenue, net income and earnings per share for each of the last 8 quarters, the latest results release and when the next one is expected.

Free, no password. An email when MRNA files with the SEC.

Next earnings date

Moderna, Inc. is expected to report around November 5, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

Latest quarter: Q2 FY2026

In Q2 FY2026 (ended June 30, 2026) Moderna, Inc. reported revenue of $145M (+2.1% on the same quarter a year earlier) and a net loss of $782M.

Diluted earnings per share were -$1.97.

Filed with the SEC on July 31, 2026.

Revenue by quarter
Q3 24: $1.9B $1.9B Q3 24Q4 24: $966M $966M Q4 24Q1 25: $108M $108M Q1 25Q2 25: $142M $142M Q2 25Q3 25: $1B $1B Q3 25Q4 25: $678M $678M Q4 25Q1 26: $389M $389M Q1 26Q2 26: $145M $145M Q2 26
Net income by quarter
Q3 24: $13M $13M Q3 24Q4 24: -$1.1B -$1.1B Q4 24Q1 25: -$971M -$971M Q1 25Q2 25: -$825M -$825M Q2 25Q3 25: -$200M -$200M Q3 25Q4 25: -$826M -$826M Q4 25Q1 26: -$1.3B -$1.3B Q1 26Q2 26: -$782M -$782M Q2 26

Quarter by quarter

QuarterEndedRevenuevs year agoNet incomeEPS
Q2 FY2026June 30, 2026$145M+2.1%-$782M-$1.97
Q1 FY2026March 31, 2026$389M+260.2%-$1.3B-$3.40
Q4 FY2025December 31, 2025$678M-29.8%-$826M-
Q3 FY2025September 30, 2025$1B-45.4%-$200M-$0.51
Q2 FY2025June 30, 2025$142M--$825M-$2.13
Q1 FY2025March 31, 2025$108M--$971M-$2.52
Q4 FY2024December 31, 2024$966M--$1.1B-
Q3 FY2024September 30, 2024$1.9B-$13M$0.03

Fourth quarters are the fiscal year minus the first three, as most companies report no separate Q4 figures.

Results filings

When is Moderna, Inc.'s next earnings date?

Moderna, Inc. is expected to report around November 5, 2026. That is an estimate from its filing rhythm (a year after the same report last year), not a date the company has announced.

What were Moderna, Inc.'s latest quarterly results?

For Q2 FY2026, which ended June 30, 2026, Moderna, Inc. reported revenue of $145M and a net loss of $782M. The figures come from its filing with the SEC.

Is Moderna, Inc.'s revenue growing?

Revenue in Q2 FY2026 was $145M, up 2.1% from $142M in the same quarter a year earlier.

Get an email when MRNA reports

Follow MRNA and we email you its next results the day they are filed, with the numbers explained.

Free, no password. An email when MRNA files with the SEC.

Source: quarterly figures Moderna, Inc. tags in its 10-Q and 10-K filings (SEC EDGAR XBRL). Not investment advice.

Everything about Moderna, Inc.